Kimberly J. Popovits, President and CEO at GENOMIC HEALTH INC (GHDX), sold 99,389 shares at $67.89 ($6.6M) on 2018-12-17, disclosed to the SEC on 2018-12-19.
Seasonal sale ($6.6M) by President and CEO — this insider has traded GHDX in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 589 | $0 | 0.0% |
| 2 | $65.85 | 7,707 | $508K | 7.7% |
| 3 | $65.85 | 7,707 | $508K | 7.7% |
| 4 | $66.78 | 9,079 | $606K | 9.2% |
| 5 | $66.78 | 9,079 | $606K | 9.2% |
| 6 | $67.89 | 7,014 |
| $476K |
| 7.2% |
| 7 | $67.89 | 7,014 | $476K | 7.2% |
| 8 | $68.53 | 1,200 | $82K | 1.2% |
| 9 | $65.79 | 4,070 | $268K | 4.1% |
| 10 | $65.79 | 4,070 | $268K | 4.1% |
| 11 | $66.74 | 17,208 | $1.1M | 17.4% |
| 12 | $66.74 | 17,208 | $1.1M | 17.4% |
| 13 | $67.46 | 3,722 | $251K | 3.8% |
| 14 | $67.46 | 3,722 | $251K | 3.8% |
| Total | $66.37 avg | 99,389 | $6.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $1.4M | — | Filing → |
| GHDX | SELL | 2019-08-14 | $7.4M | — | Filing → |
| GHDX | SELL | 2019-08-12 | $5.5M | — | Filing → |